Paolo Melloni

Investitori Associati SpA (IA) is an independent private equity firm based in Milan. Founded in 1992, IA finances their private equity transactions through their own capital as well as utilizing third-party debt financing. IA advises several private equity funds such as Investitori Associati I, II and III. Their subsidiary, Investitori Associati SGR SpA, was created to manage the closed-end investment fund, Investitori Associati IV. IA investors are financial institutions in Italy and worldwide.

Investitori Associati SpA (IA) is an independent private equity firm based in Milan. Founded in 1992, IA finances their private equity transactions through their own capital as well as utilizing third-party debt financing. IA advises several private equity funds such as Investitori Associati I, II and III. Their subsidiary, Investitori Associati SGR SpA, was created to manage the closed-end investment fund, Investitori Associati IV. IA investors are financial institutions in Italy and worldwide.

Kedrion SpA is a holding company, which engages in the production and distribution of plasma-derived therapeutic products for the treatment of hemophilia and immune system deficiencies. It offers standard intravenous immunoglobulin, human albumin solution, human rabies immunoglobulin, prothrombin complex concentrate, and fibrin sealant. Its products include Kedrab, Gammaked, Uman Complex, Kolfib, and Uman Albumin. The company was founded by Guelfo Marcucci in 2001 and is headquartered in Barga, Italy.